The Rheumatology Profile 2 (Connective Tissue) Blood Test is a diagnostic panel specifically designed to evaluate for various connective tissue diseases (CTDs) and autoimmune disorders. These diseases can affect multiple systems in the body, leading to a wide range of symptoms, including joint pain, skin rashes, fatigue, and organ dysfunction. This profile helps in diagnosing conditions such as systemic lupus erythematosus (SLE), scleroderma, rheumatoid arthritis, and Sjögren’s syndrome, among others.

Components of the Rheumatology Profile 2 (Connective Tissue) Blood Test:

1. Antinuclear Antibody (ANA) Test

  • Purpose: Screens for the presence of autoantibodies that target the nucleus of cells.
  • Indication: A positive ANA test is associated with various autoimmune diseases, particularly systemic lupus erythematosus (SLE) and other connective tissue diseases.
  • Abnormal Results: While a positive ANA can indicate an autoimmune condition, it can also be positive in healthy individuals.

2. Anti-Double-Stranded DNA (Anti-dsDNA) Antibodies

  • Purpose: Specifically detects antibodies against double-stranded DNA.
  • Indication: Strongly associated with systemic lupus erythematosus (SLE) and can be used to monitor disease activity, especially in cases of lupus nephritis.
  • Abnormal Results: Positive results indicate a higher likelihood of SLE, particularly with associated symptoms.

3. Anti-Smith (Anti-Sm) Antibodies

  • Purpose: Identifies antibodies directed against Smith antigen, a specific protein found in the nucleus.
  • Indication: Highly specific for systemic lupus erythematosus (SLE).
  • Abnormal Results: A positive result is indicative of SLE, although not all patients with lupus will test positive.

4. Anti-Ro/SSA and Anti-La/SSB Antibodies

  • Purpose: Detects antibodies associated with Sjögren’s syndrome and lupus.
  • Indication: Commonly present in patients with Sjögren’s syndrome and SLE. Anti-Ro antibodies can also be associated with photosensitivity and skin manifestations.
  • Abnormal Results: Positive results may indicate Sjögren’s syndrome or a subtype of lupus.

5. Anti-Scl-70 (Anti-Topoisomerase I) Antibodies

  • Purpose: Detects antibodies associated with scleroderma (systemic sclerosis).
  • Indication: Particularly associated with diffuse scleroderma.
  • Abnormal Results: Positive anti-Scl-70 antibodies are indicative of scleroderma but may not be present in all patients.

6. Antiphospholipid Antibodies (aPL)

  • Purpose: Measures antibodies that can increase the risk of thrombosis and pregnancy complications.
  • Indication: Associated with antiphospholipid syndrome, which can occur in conjunction with other autoimmune diseases, particularly lupus.
  • Abnormal Results: Positive results indicate a higher risk of blood clots and complications during pregnancy.

7. Complement Levels (C3 and C4)

  • Purpose: Assesses levels of complement proteins that play a role in the immune response.
  • Indication: Low complement levels can indicate active disease in conditions like lupus.
  • Abnormal Results: Decreased levels of C3 and C4 are often seen in active systemic lupus erythematosus.

8. Erythrocyte Sedimentation Rate (ESR)

  • Purpose: Measures the rate at which red blood cells settle in a tube over a specific time.
  • Indication: A nonspecific marker of inflammation, helpful in assessing disease activity.
  • Abnormal Results: Elevated ESR can indicate inflammation associated with autoimmune diseases.

Conditions Often Assessed with Rheumatology Profile 2:

  • Systemic Lupus Erythematosus (SLE)
  • Scleroderma (Systemic Sclerosis)
  • Sjögren’s Syndrome
  • Mixed Connective Tissue Disease (MCTD)
  • Rheumatoid Arthritis (RA)
  • Antiphospholipid Syndrome

When Is the Rheumatology Profile 2 Test Ordered?

  • When patients present with symptoms of autoimmune diseases, such as joint pain, rashes, or fatigue.
  • To help confirm a suspected diagnosis of connective tissue diseases.
  • To monitor disease activity and treatment response in known autoimmune conditions.

Conclusion:

The Rheumatology Profile 2 (Connective Tissue) Blood Test is a valuable tool in diagnosing and monitoring autoimmune and connective tissue diseases. By assessing various autoantibodies and inflammatory markers, healthcare providers can gain insights into a patient’s condition and tailor treatment strategies accordingly. This comprehensive approach aids in managing chronic autoimmune disorders and improving patient outcomes.

Results – 3 days from Laboratory receiving sample

Back to Blood Tests